Skip to main content

Covid-19 Mrna (Pfizer) Vaccine Dosage

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for COVID-19

For investigational use only

Booster Dose: 0.3 mL IM once, at least 2 months after administration of completion of a primary vaccination or booster dose

Comments:


Use: Active immunization to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) original and Omicron BA.4/BA.5

Usual Pediatric Dose for COVID-19

For investigational use only

12 years and older:


Comments:

Use: Active immunization to prevent COVID-19 caused by SARS-CoV-2 original and Omicron BA.4/BA.5

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS: Patients with known history of severe allergic reaction to the active component or any of the ingredients

Safety and efficacy have not been established in patients younger than 12 years.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

General:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.